EMERYVILLE, Calif.,
Dec. 23, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic
biotechnology company accelerating the world's transition to
sustainable consumption through its Lab-to-MarketTM
operating platform, today announced the completion of a previously
announced joint venture agreement with MF 92 VENTURES LLC
("Minerva"), a Minerva Foods subsidiary, to develop molecules for
the sustainable production and distribution of animal protein ("the
Joint Venture").
The Joint Venture between Amyris and Minerva will be focused on
enhancing the sustainability of the Brazilian meat exporting
market, which is the largest in the world. Minerva and Amyris will
collaborate on the development, scale-up and production of new
target molecules, which Minerva will fund and bring to market
commercially. The new molecules will target several sustainability
objectives, including improving and lowering the carbon intensity
of producing animal protein; sustainable packaging; and
fermentation-based, natural preservatives that facilitate the
transport of meat around the world. Additionally, the parties
expect to work on the production of fermentation-based protein as
an alternative to animal-based protein.
Relevant regulatory approvals have been attained for the
development and scale-up of a vertical technology and
commercialization platform that aims to transform the way protein
is produced. The Joint Venture is expected to generate first
license revenue for Amyris before the end of 2021 and deliver first
commercial production of its initial targets in 2022.
"We are very pleased to partner with Amyris, the leader in
synthetic biotechnology and the world's leading fermentation
technology company," said Fernando Galletti
De Queiroz, Chief Executive Officer of Minerva. "We have a
strong track record of commercializing innovative technologies for
producing animal protein and reducing carbon emissions. With
Amyris' clean fermentation technology, we expect to lead the
disruption of the animal protein industry and reduce our industry's
carbon footprint."
"We are excited to further expand the reach of our technology
and manufacturing expertise through our partnership with Minerva
Foods. We believe this collaboration will accelerate the
commercialization of natural, sustainably produced molecules that
are capable of transforming the production and supply chain of
animal protein," commented John
Melo, President and Chief Executive Officer of Amyris. "We
have a proven track record in biotechnology of developing and
scaling molecules that are transforming several vertical markets.
We are executing well and are on track for a strong fourth
quarter."
About Minerva Foods
Minerva S.A. or Minerva Foods (BVMF: BEEF3) is the largest exporter
of beef in South America and one
of the leading companies in Brazil
for the production and sale of both in natura (chilled) and frozen
beef, processed protein products, live cattle, and sub-products.
Minerva Foods was founded in 1992 in the city of Barretos, in the
countryside of the State of São Paulo, where it is headquartered.
From the beginning, Minerva Foods has had a clear goal of expanding
globally and diversifying its operations geographically. In
2017, the company acquired nine beef abattoirs in South America, establishing itself as the most
diversified beef producer in terms of location, products offered,
and presence in the external markets. Minerva Foods now operates
plants in Brazil, Argentina, Colombia, Paraguay, and Uruguay.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-MarketTM operating platform. This Amyris platform
leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products.
Forward-Looking Statements
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding Amyris' plans to develop, scale and
produce new target molecules, as supported through funding provided
by Minerva, and the timing thereof, in a joint venture;
expectations of commencing manufacturing and sales in 2022;
expectations that the molecules will enable meat to be transported
and sold with a longer shelf-life at reduced CO2
emission levels; the potential that the parties may develop and
produce a fermentation-based alternative to animal-based protein;
and Amyris' expectations regarding short- and long-term revenue and
growth potential derived from its joint venture with Minerva. These
statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties; potential delays or failures in development,
production, regulatory approval and commercialization of new
molecules and products; failure to realize the expected benefits of
the Joint Venture with Minerva; risks related to Amyris' reliance
on third parties (including in the supply chain); and other risks
detailed from time to time in filings Amyris makes with the
Securities and Exchange Commission, including Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. Amyris disclaims any obligation to update information
contained in these forward-looking statements, whether as a result
of new information, future events, or otherwise.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-and-minerva-foods-complete-joint-venture-and-license-agreements-to-scale-low-carbon-protein-production-platform-301450267.html
SOURCE Amyris, Inc.